Group 1: Corporate Actions - Mitsubishi Chemical announced the transfer of its wholly-owned subsidiary J-Film Corporation to a special purpose entity of Marubeni Capital Fund III, expected to be completed by December 29, 2025. This decision follows the recent exit from the polyester resin manufacturing business for printer toner, driven by a new mid-term management plan for 2029 [3]. - Evonik has initiated the dissolution and liquidation of its joint venture with Shandong Weilan Biotechnology due to changes in the market environment and unmet operational expectations. The joint venture was established to develop gut health solutions for livestock in the Chinese market [4]. - Hexion reported a 10% workforce reduction as part of cost-cutting measures, including the closure of its maleic anhydride plant in Germany and other downstream facilities in Europe and North America, due to decreased global construction and industrial activity [6]. Group 2: Financial Performance - Mitsubishi Chemical's Q1 2025 sales revenue was 880.65 billion yen, a 13.4% decrease year-on-year, with net profit down 36.1% to 35.968 billion yen, and attributable net profit down 50.5% to 19.627 billion yen, largely impacted by overall economic slowdown and U.S. trade policies [3]. - Evonik's Q2 2025 sales fell by 11% to 3.5 billion euros, with over half of the decline attributed to unfavorable currency fluctuations and the divestment of its superabsorbent polymers business. Adjusted EBITDA decreased by 12% to 509 million euros [4][5]. - Hexion's H1 2025 revenue was $2.868 billion, down 6% year-on-year, with a net loss of $163 million compared to a net loss of $15 million in the same period last year. Adjusted EBITDA fell by 31.1% [6].